» Articles » PMID: 24035314

RNA Silencing Targeting PIN (protein Inhibitor of Neuronal Nitric Oxide Synthase) Attenuates the Development of Hypertension in Young Spontaneously Hypertensive Rats

Overview
Publisher Elsevier
Date 2013 Sep 17
PMID 24035314
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) deficiency contributes to hypertension. We previously showed that neuronal nitric oxide synthase (nNOS) was involved in hypertension and kidney damage in spontaneously hypertensive rats (SHRs). The protein inhibitor of nNOS (PIN) has been reported to inhibit activity of nNOS.Thus, we tested whether increased PIN in the kidney results in hypertension and whether small interfering RNA (siRNA) targeting PIN attenuates hypertension in SHRs. Four-week-old male SHRs were assigned into three groups (n = 6-7/group): SHR; SHR + PIN, SHR that received siRNA targeting PIN; and SHR + NC, SHR treated with random negative control siRNA. Rats were sacrificed at 12 weeks of age. PIN protein expression was inhibited considerably when PIN siRNA was transfected into NRK52E cells (90% siRNA at 1 nM). The increases of BP were attenuated by siRNA targeting PIN in 12-week-old SHRs. Immunostaining of nNOS-α and total nNOS was greater in SHR + PIN group than SHR. Moreover, renal superoxide production and 8-hydroxydeoxyguanosine (8-OHdG) staining were more decreased in the SHR + PIN group than SHRs. We conclude that PIN siRNA reduced PIN expression in vitro and in vivo. PIN siRNA therapy attenuates hypertension in SHRs at 12 weeks of age. Our results suggest that PIN is involved in the development of hypertension.

Citing Articles

Downregulation of neuronal nitric oxide synthase (nNOS) within the paraventricular nucleus in Ins2-type-1 diabetic mice contributes to sympatho-excitation.

Patel T, Gao L, Boomer S, Liu X, Patel K, Zheng H Nitric Oxide. 2024; 154():1-7.

PMID: 39521242 PMC: 11729414. DOI: 10.1016/j.niox.2024.11.001.


Renal Inflammation, Oxidative Stress, and Metabolic Abnormalities During the Initial Stages of Hypertension in Spontaneously Hypertensive Rats.

Wojtacha P, Bogdanska-Chomczyk E, Majewski M, Obremski K, Majewski M, Kozlowska A Cells. 2024; 13(21.

PMID: 39513878 PMC: 11545559. DOI: 10.3390/cells13211771.


Emerging RNAi Therapies to Treat Hypertension.

Daga P, Singh G, Menon T, Sztukowska M, Kalra D Mol Diagn Ther. 2024; 29(1):25-41.

PMID: 39400663 DOI: 10.1007/s40291-024-00747-5.


Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension.

Sharma N, Haibara A, Katsurada K, Liu X, Patel K Nitric Oxide. 2019; 94:54-62.

PMID: 31654775 PMC: 6911640. DOI: 10.1016/j.niox.2019.10.007.


Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ.

Ren G, Zheng X, Bommarito M, Metzger S, Walia Y, Letson J Sci Rep. 2019; 9(1):6688.

PMID: 31040372 PMC: 6491486. DOI: 10.1038/s41598-019-43239-x.